Mukka Proteins to hold 16th AGM on Sep 10, 2026, via VC/OVAM
Mukka Proteins Limited will hold its 16th Annual General Meeting on September 10, 2026, at 3:00 PM IST via Video Conferencing. The Annual Report for FY 2025-26 and AGM notice are being sent electronically to registered shareholders. A weblink is provided for shareholders with unregistered email addresses.
This is a standard regulatory communication regarding the upcoming AGM and access to the annual report. It does not involve any new financial performance, strategic changes, or material events that would significantly impact the company's stock or operations.
The announcement is a routine procedural update regarding the Annual General Meeting and the dispatch of the annual report. It does not contain any new financial information or significant business developments that would impact the sentiment.
Mukka Proteins Limited has announced the dispatch of letters to shareholders whose email addresses are not registered with the company or depositories. These letters provide a weblink to access the Annual Report for FY 2025-26 and the Notice of the upcoming Annual General Meeting (AGM).
The 16th AGM of shareholders is scheduled to be held on Thursday, 10th September 2026, commencing at 3:00 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OVAM).
Shareholders are urged to register their missing KYC details. Forms for this purpose can be downloaded from the company's website or the website of its Registrar and Transfer Agent (RTA), Cameo Corporate Services Limited. For faster redressal of investor queries, shareholders can utilize the WISDOM portal provided by the RTA.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.